DK1500390T3 - Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1500390T3
DK1500390T3 DK03016945T DK03016945T DK1500390T3 DK 1500390 T3 DK1500390 T3 DK 1500390T3 DK 03016945 T DK03016945 T DK 03016945T DK 03016945 T DK03016945 T DK 03016945T DK 1500390 T3 DK1500390 T3 DK 1500390T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
dosage form
solid dosage
preparation
desmopressin
Prior art date
Application number
DK03016945T
Other languages
English (en)
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1500390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK1500390T3 publication Critical patent/DK1500390T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
DK03016945T 2003-07-25 2003-07-25 Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf DK1500390T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03016945A EP1500390B1 (en) 2003-07-25 2003-07-25 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
US10/626,857 US7022340B2 (en) 2003-07-25 2003-07-25 Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Publications (1)

Publication Number Publication Date
DK1500390T3 true DK1500390T3 (da) 2005-09-19

Family

ID=34117527

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03016945T DK1500390T3 (da) 2003-07-25 2003-07-25 Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (1) US7022340B2 (da)
EP (1) EP1500390B1 (da)
JP (1) JP4430673B2 (da)
KR (1) KR20050104331A (da)
AT (1) ATE301990T1 (da)
AU (1) AU2004260625B2 (da)
BR (1) BRPI0412905A (da)
CA (1) CA2490335C (da)
DE (1) DE60301351T2 (da)
DK (1) DK1500390T3 (da)
ES (1) ES2243840T3 (da)
HK (1) HK1072009A1 (da)
IL (1) IL187591A0 (da)
MX (1) MXPA06000903A (da)
NO (1) NO327328B1 (da)
NZ (1) NZ544104A (da)
PL (1) PL379704A1 (da)
PT (1) PT1500390E (da)
RU (1) RU2303439C2 (da)
SI (1) SI1500390T1 (da)
TW (1) TWI268782B (da)
WO (1) WO2005011640A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
EP1530967B1 (en) * 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
US20090232896A1 (en) * 2008-03-11 2009-09-17 Mallinckrodt Inc. Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT3225249T (lt) * 2008-05-21 2019-01-10 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2010038698A1 (ja) * 2008-09-30 2010-04-08 三井化学株式会社 繊維強化樹脂組成物およびその成形体

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
WO1995018602A1 (en) 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en) 1995-12-23 1996-02-28 Knoll Ag Therapeutic agents
DE19602757A1 (de) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
WO2000009423A1 (es) 1998-08-11 2000-02-24 Jaime Marti Sala Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
DE60128902T2 (de) 2000-04-17 2008-02-14 Vectura Ltd., Chippenham Formulierungen zur verwendung in inhalationsvorrichtungen
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0010709D0 (en) 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
ES2632461T3 (es) 2000-06-27 2017-09-13 Vectura Limited Formulaciones para su uso en dispositivos inhaladores
EP1435922A1 (de) 2001-10-15 2004-07-14 Röhm GmbH & Co. KG Verwendung eines copolymeren zur herstellung einer arzneiform, die als wirkstoff ein peptid oder protein enthält
DE60307082D1 (de) 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
DK1473029T3 (da) * 2003-04-30 2005-04-18 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Also Published As

Publication number Publication date
US20050019392A1 (en) 2005-01-27
DE60301351T2 (de) 2006-01-19
RU2005141230A (ru) 2006-07-10
WO2005011640A2 (en) 2005-02-10
AU2004260625B2 (en) 2007-12-06
DE60301351D1 (de) 2005-09-22
PL379704A1 (pl) 2006-11-13
NO20051896L (no) 2005-04-19
TW200509995A (en) 2005-03-16
BRPI0412905A (pt) 2006-09-26
MXPA06000903A (es) 2006-05-04
CA2490335A1 (en) 2005-01-25
US7022340B2 (en) 2006-04-04
EP1500390B1 (en) 2005-08-17
EP1500390A1 (en) 2005-01-26
AU2004260625A1 (en) 2005-02-10
CA2490335C (en) 2006-01-31
KR20050104331A (ko) 2005-11-02
NZ544104A (en) 2008-06-30
TWI268782B (en) 2006-12-21
HK1072009A1 (en) 2005-08-12
ES2243840T3 (es) 2005-12-01
RU2303439C2 (ru) 2007-07-27
JP4430673B2 (ja) 2010-03-10
JP2007517762A (ja) 2007-07-05
SI1500390T1 (sl) 2006-02-28
PT1500390E (pt) 2005-10-31
WO2005011640A3 (en) 2005-03-24
ATE301990T1 (de) 2005-09-15
NO327328B1 (no) 2009-06-08
IL187591A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
TW200518743A (en) Rapid dissolution formulation of a calcium receptor-active compound
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
MY148773A (en) Galenic formulations of organic compounds
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
TW200606164A (en) New compounds
TW200505823A (en) CaSR antagonist
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
TW200800984A (en) New compounds
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SE0102440D0 (sv) New compound
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
NO331205B1 (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
HK1075894A1 (en) Prucalopride-n-oxide
WO2003037916A3 (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0212410D0 (en) Organic compounds
EA200401082A1 (ru) Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат
TW200518749A (en) Stabilised pharmaceutical compositions
EP1452522A3 (en) Novel compounds and compositions as protease inhibitors